Latest Conference Articles

A Case of Biologic Switching in Psoriasis and How to Optimize Outcomes with Ron Vender, MD

A Case of Biologic Switching in Psoriasis and How to Optimize Outcomes with Ron Vender, MD

February 17th 2025

Dermatology Winter Clinical

Switching biologic treatment for patients with moderate to severe psoriasis, needn't be daunting, Vender said; he works through a tricky case that ended very well.

Pearls for Solving Problems when Treating Psoriasis: From the Experts

Pearls for Solving Problems when Treating Psoriasis: From the Experts

February 16th 2025

Dermatology Winter Clinical

Dermatology experts share pearls to help when biologics alone are not enough, when obesity is a comorbidity with psoriasis, and when isotype switching derails therapy.

Topical Acne Therapies: A Clinical Update

Topical Acne Therapies: A Clinical Update

February 16th 2025

Dermatology Winter Clinical

Insights include new data on combination therapies, topical antiandrogens, and innovative retinoid formulations.

Alopecia Areata: Emerging Data and Treatment Approaches

Alopecia Areata: Emerging Data and Treatment Approaches

February 16th 2025

Dermatology Winter Clinical

JAK inhibitors are being used widely and successfully to treat alopecia areata, and Amy McMichaels, MD, showcased data and also discussed patient communication.

The Great Atopic Dermatitis Treatment Debate: Biologics vs JAK Inhibitors

The Great Atopic Dermatitis Treatment Debate: Biologics vs JAK Inhibitors

February 15th 2025

Dermatology Winter Clinical

There really is no debate - it's all about individualizing treatment for the patient, but Drs Neal Bhatia and Raj Chovatiya went head to head at Midwinter Hawaii.

Key Advances in Oral Therapies for Psoriasis Unveiled at Winter Clinical Dermatology Conference 2025

Key Advances in Oral Therapies for Psoriasis Unveiled at Winter Clinical Dermatology Conference 2025

February 15th 2025

Dermatology Winter Clinical

April Armstrong, MD, discussed the latest data on apremilast, deucravacitinib, and emerging TYK2 and IL-23 inhibitors at Midwinter Hawaii.

60 Tips in 60 Minutes: Day 1 at the 2025 Midwinter Clinical Hawaii Dermatology Conference 

60 Tips in 60 Minutes: Day 1 at the 2025 Midwinter Clinical Hawaii Dermatology Conference 

February 15th 2025

Dermatology Winter Clinical

The dermatologic tips offered in this short slide show come from 4 renowned professionals and reflect their subspecialties.

The 2025 Winter Clinical Hawaii Dermatology Conference: Saturday Preview

The 2025 Winter Clinical Hawaii Dermatology Conference: Saturday Preview

February 14th 2025

Dermatology Winter Clinical

The 2025 Winter Clinical Hawaii kicks off today with the first full day of educational sessions starting tomorrow, February 15 - here's what to look for.

5 Days in Hawaii: The Winter Clinical Hawaii Dermatology Conference

5 Days in Hawaii: The Winter Clinical Hawaii Dermatology Conference

February 13th 2025

Dermatology Winter Clinical

The Winter Clinical Hawaii Dermatology Conference will kick off on the Big Island on February 14th. Check out the agenda and the option to attend virtually.

Dupilumab, Tezepelumab Gain Ground for Severe Asthma but Overall Biologic Adherence Rates Found Low: 2 Studies from 2025 AAAAI/WAO

Dupilumab, Tezepelumab Gain Ground for Severe Asthma but Overall Biologic Adherence Rates Found Low: 2 Studies from 2025 AAAAI/WAO

February 12th 2025

AAAAI

AAAAI 2025. One study found the 2 newer biologics have been prescribed more frequently while the other suggests asthma treatment may not be optimal or even consistent.